Email Updates

You are here

Home

9 JULY 2021 VOLUME 23 ISSUE 27

Media Coverage

  • Kenya: Funding Cuts Threaten HIV/AIDS Treatment Efforts

    HIV positive people fear losing access to free treatment services as Kenya coasts towards a crisis while donor funding declines amid insufficient domestic funds, reveals a NationNewsplex review of HIV financing.

    July 8, 2021
    Treatment
    All Africa

  • ‘This Will Shut Us Down’: HIV Prevention Clinics Brace for Gilead Reimbursement Cuts

    Tony Christon-Walker was determined to set up an HIV prevention clinic in Birmingham, Alabama, that would succeed where others have long struggled to combat the scourge of the virus among his fellow queer Black men.

    July 7, 2021
    PrEP
    NBC News

  • Phase 1 HIV Mosaic Vaccine Study Launched at Oxford University

    On 5 July 2021, researchers at Oxford University published a press release for the launch of a phase 1 study of an HIV vaccine. The HIV-CORE 0052 study will enroll 13 HIV negative participants who are not at high risk of catching HIV. It will use a mosaic vaccine called HIVconsvX that targets different sections of the virus. The vaccines will use two doses, four weeks apart.

    July 7, 2021
    HIV Vaccine
    i-Base

  • Circumcisions Cut as South Africa Focuses on the Battle Against COVID-19

    Government’s move to direct all medical resources at the fight against COVID-19 has scuppered the hopes of many boys and men across the country who are waiting to undergo circumcision procedures.

    July 7, 2021
    Voluntary Medical Male Circumcision
    Health-E News

  • Why Aren’t Diseases Like HIV and Malaria, Which Still Kill Millions of People a Year, Called Pandemics?

    The furor about vaccine nationalism and sharing doses of COVID-19 overshadows a fundamental issue: What is an equitable definition of what counts as a pandemic? The use of that word isn’t just semantics: It’s about who we care lives or dies.

    July 6, 2021
    General
    STAT

  • New PrEP Guidelines Aim to Expand Access, but Uptake Will Depend on Clinicians

    For the first time in four years, the Centers for Disease Control and Prevention (CDC) last month issued updates to the HIV Preexposure Prophylaxis (PrEP) Clinical Practice Guidelines and Providers Supplement, changes that broaden criteria for who may be offered PrEP and include expanded ways to use it. Additions include options that weren’t available when the 2017 PrEP guidelines were written, notably telehealth for PrEP and intramuscular cabotegravir (CAB LA) injections, expected to be approved by the Food and Drug Administration (FDA).

    July 6, 2021
    PrEP
    The BodyPro

  • Easy-To-Access PEP Pilot Shows Promise in Rural East Africa

    The first pilot post-exposure prophylaxis (PEP) to people in parts of rural Kenya and Uganda where HIV prevalence is high has resulted in good uptake and no new HIV infections.

    July 5, 2021
    General
    Avert

  • I Thought HIV Meant Death but It Led Me to Fight to Save Millions of Lives

    In 2001, at the age of 22 – when I thought my life had just begun – I was diagnosed with HIV. At that time, the diagnosis felt like a death sentence. Every day, I waited for my hour to die. However, after two months of waiting, death didn’t come. Instead, a comrade arrived and took me to the offices of the Treatment Action Campaign (TAC) – a South African group fighting for access to HIV treatment for all. There, I met other people living with HIV for the first time.

    July 5, 2021
    General
    The Guardian

  • People With HIV Are Highly Satisfied With Cabenuva

    People with HIV who received long-acting Cabenuva preferred the monthly or bimonthly injections over their previous daily oral regimen, and those who tried both dosing schedules favored less frequent administration, according to study results published in Patient-Centered Outcomes Research.

    July 5, 2021
    Treatment
    POZ

  • ‘Our Work Is Not Done’: The True Story of America’s Response to HIV/AIDS in Sub-Saharan Africa

    Introduced in 2003, the US President’s Emergency Plan for AIDS Relief, or PEPFAR, as it is widely known, played a salient role in decreasing HIV cases and AIDS deaths in sub-Saharan Africa, despite the attempt by American politics to get in the way. Describing the inside/outside strategies used to save lives and the genius of the activists of that time, Emily Bass provides a playbook for combating current and future pandemics in her book, To End a Plague: America’s Fight to Defeat AIDS in Africa (available July 6).

    July 5, 2021
    General
    The Body

  • HIV Generic Drug for Babies Distributed in Africa, Says UNITAID

    Aid agencies have distributed a strawberry-flavoured tablet for children living with HIV in six African countries, the first generic pediatric version of a key anti-retroviral, global health agency UNITAID said on Sunday.

    July 4, 2021
    Treatment
    Reuters

  • Carl Schmid on the “Game-Changer” Innovations to Help End HIV

    How is the US doing in its battle to end the HIV epidemic? It’s heading in the right direction but at a slower-than-desired pace, according to a major report issued by the CDC at the end of May. Its conclusion could be summed up in one line: “Hopeful signs of progress in HIV prevention, but gains remain uneven.”

    July 3, 2021
    PrEP
    Queerty

  • Kenya Inches Closer to Producing Own Vaccines

    Kenya's dependency on foreign vaccine manufacturers could soon end. This is after top scientists launched the Sisulu Foundation for African and Pandemic Disease Response on Thursday. The Foundation brings together top researchers and research institutes in vaccines and virology from the continent including the KAVI institute for Clinical research at the University of Nairobi.

    July 1, 2021
    General
    The Star

Published Research

Announcements